As health care is changing rapidly, and employers want creative, innovative thinkers who have ideas on how to do things better. And no matter where you work in the massive health care industry, what is your opinion on this topic.
Here are a few recent interesting papers on the subject:
Hoeft TJ, Fortney JC, Patel V, Unützer J. Task-Sharing Approaches to Improve Mental Health Care in Rural and Other Low-Resource Settings: A Systematic Review. J Rural Health 2018;34(1):48-62. http://onlinelibrary.wiley.com/doi/10.1111/jrh.12229/epdf
Addario BJ, Fadich A, Fox J, Krebs L, Maskens D, Oliver K, Schwartz E, Spurrier-Bernard G, Turnham T. Patient value: Perspectives from the advocacy community. Health Expect 2018;21(1):57-63. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750698/pdf/HEX-21-57.pdf
Hatcher S, Whittaker R, Patton M, Miles WS, Ralph N, Kercher K, Sharon C. Web-based Therapy Plus Support by a Coach in Depressed Patients Referred to Secondary Mental Health Care: Randomized Controlled Trial. JMIR Ment Health 2018;5(1):e5. http://mental.jmir.org/article/viewFile/mental_v5i1e5/2
Agyepong IA, Sewankambo N, Binagwaho A, Coll-Seck AM, Corrah T, Ezeh A et al. The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa. Lancet 2018;390(10114):2803-2859. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31509-X/abstract
Bouayad L, Ialynytchev A, Padmanabhan B. Patient Health Record Systems Scope and Functionalities: Literature Review and Future Directions. J Med Internet Res 2017;19(11):e388. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707430/
Keteyian CK, Nallamothu BK, Ryan AM. The hospital tech laboratory: quality innovation in a new era of value-conscious care. Am J Manag Care 2017;23(8):501-504. http://www.ajmc.com/journals/issue/2017/2017-vol23-n8/the-hospital-tech-laboratory-quality-innovation-in-a-new-era-of-value-conscious-care?p=1
Myers SS. Planetary health: protecting human health on a rapidly changing planet. Lancet 2018;390(10114):2860-2868. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32846-5/fulltext and https://www.youtube.com/watch?v=tQ0JNwQ4Vfw
Here some more 'future research areas' in medicine:
Greenman J. Looking to the future of organs-on-chip. Future Sci OA 2017;3(2):FSO205. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481857/pdf/fsoa-03-205.pdf
Wikswo JP. Looking to the future of organs-on-chips: interview with Professor John Wikswo. Future Sci OA 2017;3(2):FSO163. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481807/pdf/fsoa-03-163.pdf
Ugolini GS, Visone R, Cruz-Moreira D, Redaelli A, Rasponi M. Tailoring cardiac environment in microphysiological systems: an outlook on current and perspective heart-on-chip platforms. Future Sci OA 2017;3(2):FSO191. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481859/pdf/fsoa-03-191.pdf
Rogal J, Probst C, Loskill P. Integration concepts for multi-organ chips: how to maintain flexibility?! Future Sci OA 2017;3(2):FSO180. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481865/pdf/fsoa-03-180.pdf
Heaney LM, Jones DJ, Suzuki T. Mass spectrometry in medicine: a technology for the future? Future Sci OA 2017;3(3):FSO213. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583653/pdf/fsoa-03-213.pdf
Zhang YS. Engineering challenges in microphysiological systems. Future Sci OA 2017;3(3):FSO209. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583656/pdf/fsoa-03-209.pdf
Carbonero F. Human epigenetics and microbiome: the potential for a revolution in both research areas by integrative studies. Future Sci OA 2017;3(3):FSO207. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583657/pdf/fsoa-03-207.pdf
Hu Y, Bajorath J. Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited. Future Sci OA 2017;3(2):FSO179. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481856/pdf/fsoa-03-179.pdf
Borba MACSM, Castelletti CHM, Filho JLL, Martins DBG. Point-of-care devices: the next frontier in personalized chemotherapy. Future Sci OA 2017;3(3):FSO219. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583650/pdf/fsoa-03-219.pdf
Zhang J, Wei X, Zeng R, Xu F, Li X. Stem cell culture and differentiation in microfluidic devices toward organ-on-a-chip. Future Sci OA. 2017;3(2):FSO187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481871/pdf/fsoa-03-187.pdf
Obermeyer Z, Lee TH. Lost in Thought — The Limits of the Human Mind and the Future of Medicine. N Engl J Med 217;377:1209-1211. http://www.nejm.org/doi/pdf/10.1056/NEJMp1705348
Mayo Clinic CEO John Noseworthy, M.D. recently took part in an interview with the Wall Street Journal and joined MSNBC’s Morning Joe. He took both opportunities to talk about the trend toward forming contracts with large corporations for certain types of specialty care. 📷
Mayo Clinic has had a relationship with Walmart for 18 years in which Walmart associates needing organ transplants are sent to one of the Mayo Clinic for evaluation and care. That relationship has expanded and now patients facing breast, colorectal and lung cancers are sent to Mayo Clinic for evaluation and treatment.
“If you are an employee at Wal-Mart and you unfortunately get one of these conditions, Wal-Mart will pay for an evaluation at Mayo Clinic, and all treatments and evaluations necessary including traveling to Mayo Clinic with a caretaker,” Dr. Noseworthy told the Wall Street Journal.
“It is an extraordinary benefit but it makes sense for Wal-Mart because the diagnosis will be accurate, the care will be as safe as it can be, and cutting-edge as it can be and the patient can get back to work. They’ve recognized that the avoided cost for complex care in a highly engineered system like Mayo saves them money,” he added.
These kinds of relationships likely will grow in health care.
“This is a trend. There are a number of groups that do this,” Dr. Noseworthy explained during the Morning Joe segment. “Complex health care is very expensive, and it’s important to get it right the first time.”